Clinical Trial Update: Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating a combination of paclitaxel, cyclophosphamide, doxorubicin, autologous dendritic cells, and surgery in women with stage II/III breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Autologous dendritic cells
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Nebraska | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-02